LIG4 and COVID-19: These included nucleoside analogues, topoisomerase poisons, candidate DNA repair enzyme inhibitors, compounds reported to inhibit other COVID-19 targets, and antivirals believed to interfere with nucleic acid metabolism (Supplementary Table 2).